Nodular regenerative hyperplasia: Evolving concepts on under diagnosed cause of portal hypertension

World Journal of Gastroenterology

Volumn 17, Issue 11, 2011, Pages 1400-1409

  Hartleb, Marek ^a   Gutkowski, Krzysztof ^a   Milkiewicz, Piotr ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Comorbidities; Nodular regenerative hyperplasia; Portal hypertension

Indexed keywords

AZATHIOPRINE; BUSULFAN; CYCLOPHOSPHAMIDE; DIURETIC AGENT; GADOLINIUM; MERCAPTOPURINE; OXALIPLATIN; TIOGUANINE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANTIPHOSPHOLIPID SYNDROME; APLASTIC ANEMIA; ARTICLE; CELIAC DISEASE; CHRONIC GLOMERULONEPHRITIS; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; CRYOGLOBULINEMIA; CYSTINOSIS; DISEASE ASSOCIATION; DISEASE COURSE; ESOPHAGUS VARICES; FELTY SYNDROME; GLOBOID CELL LEUKODYSTROPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LUNG FIBROSIS; LYMPHOMA; MACROGLOBULINEMIA; MYASTHENIA; MYELOPROLIFERATIVE DISORDER; NODULAR HYPERPLASIA; NODULAR REGENERATIVE HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYARTERITIS NODOSA; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIMARY BILIARY CIRRHOSIS; PROGNOSIS; PULMONARY HYPERTENSION; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SODIUM RESTRICTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT OUTCOME; TURNER SYNDROME; VASCULAR DISEASE;

EID: 79955965170     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i11.1400     Document Type: Article

References (169)

1. Hillaire S, Bonte E, Denninger MH, Casadevall N, Cadranel JF, Lebrec D, Valla D, Degott C. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002; 51: 275-280
2. Steiner PE. Nodular regenerative hyperplasia of the liver. Am J Pathol 1959; 35: 943-953
3. Mahamid J, Miselevich I, Attias D, Laor R, Zuckerman E, Shaoul R. Nodular regenerative hyperplasia associated with idiopathic thrombocytopenic purpura in a young girl: a case report and review of the literature. J Pediatr Gastroenterol Nutr 2005; 41: 251-255
4. Naber AH, Van Haelst U, Yap SH. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J Hepatol 1991; 12: 94-99
5. Nakanuma Y, Hoso M, Sasaki M, Terada T, Katayanagi K, Nonomura A, Kurumaya H, Harada A, Obata H. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996; 28: 195-204
6. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11: 787-797
7. Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006; 44: 7-14
8. Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol 1990; 12: 460-465
9. Colina F, Alberti N, Solis JA, Martinez-Tello FJ. Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases. Liver 1989; 9: 253-265
10. Elariny HA, Mizrahi SS, Hayes DH, Boudreaux JP, Hussey JL, Farr GH Jr. Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation. Transpl Int 1994; 7: 309-313
11. Dumortier J, Boillot O, Chevallier M, Berger F, Potier P, Valette PJ, Paliard P, Scoazec JY. Familial occurrence of nodular regenerative hyperplasia of the liver: a report on three families. Gut 1999; 45: 289-294
12. González-Huezo MS, Villela LM, Zepeda-Florencio Mdel C, Carrillo-Ponce CS, Mondragón-Sánchez RJ. Nodular regenerative hyperplasia associated to aplastic anemia: a case report and literature review. Ann Hepatol 2006; 5: 166-169
13. Al-Hamoudi WK, Pasieka JL, Urbanski SJ, Lee SS. Hepatic nodular regenerative hyperplasia in a patient with advanced carcinoid tumor. Eur J Gastroenterol Hepatol 2009; 21: 1083-1085
14. Fukai T, Ishibashi H, Noda T, Dohmen K, Kudo J, Nagafuchi S, Sueishi K, Yamasaki T, Sameshima H. Nodular regenerative hyperplasia of the liver with portal vein thrombosis and hyperplasia of the adrenal gland. Gastroenterol Jpn 1992; 27: 108-114
15. McDonald JA, Painter DM, Gallagher ND, McCaughan GW. Nodular regenerative hyperplasia mimicking cirrhosis of the liver. Gut 1990; 31: 725-727
16. Buster EH, van Vuuren HJ, Zondervan PE, Metselaar HJ, Tilanus HW, de Man RA. Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine. Eur J Gastroenterol Hepatol 2008; 20: 68-72
17. Shastri S, Dubinsky MC, Fred Poordad F, Vasiliauskas EA, Geller SA. Early nodular hyperplasia of the liver occurring with inflammatory bowel diseases in association with thioguanine therapy. Arch Pathol Lab Med 2004; 128: 49-53
18. Gane E, Portmann B, Saxena R, Wong P, Ramage J, Williams R. Nodular regenerative hyperplasia of the liver graft after liver transplantation. Hepatology 1994; 20: 88-94
19. Teml A, Schwab M, Hommes DW, Almer S, Lukas M, Feich-tenschlager T, Florin T, Seiderer J, Petritsch W, Bokemeyer B, Kreisel W, Herrlinger KR, Knoflach P, Bonaz B, Klugmann T, Herfarth H, Pedarnig N, Reinisch W. A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease. Wien Klin Wochenschr 2007; 119: 519-526
20. Mallet V, Blanchard P, Verkarre V, Vallet-Pichard A, Fontaine H, Lascoux-Combe C, Pol S. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIVinfected patients. AIDS 2007; 21: 187-192
21. Vispo E, Moreno A, Maida I, Barreiro P, Cuevas A, Albertos S, Soriano V. Noncirrhotic portal hypertension in HIVinfected patients: unique clinical and pathological findings. AIDS 2010; 24: 1171-1176
22. Ryan P, Nanji S, Pollett A, Moore M, Moulton CA, Gallinger S, Guindi M. Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy. Am J Surg Pathol 2010; 34: 784-791
23. Rubbia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu AX, Brezault C, Soubrane O, Abdalla EK, Vauthey JN, Mentha G, Terris B. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin- associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 2010; 56: 430-439
24. O'Brien K, Hussain N, Warady BA, Kleiner DE, Kleta R, Bernardini I, Heller T, Gahl WA. Nodular regenerative hyperplasia and severe portal hypertension in cystinosis. Clin Gastroenterol Hepatol 2006; 4: 387-394
25. Riviere E, Vergniol J, Reffet A, Lippa N, Le Bail B, de Ledinghen V. Gastric variceal bleeding uncovering a rare association of CREST syndrome, primary biliary cirrhosis, nodular regenerative hyperplasia and pulmonary hypertension. Eur J Gastroenterol Hepatol 2010; 22: 1145-1148
26. Arotçarena R, Calès V, Berthelémy P, Parent Y, Malet M, Etcharry F, Ferrari S, Pariente A. Severe sinusoidal lesions: a serious and overlooked complication of oxaliplatin-containing chemotherapy? Gastroenterol Clin Biol 2006; 30: 1313-1316
27. Colmegna I, deBoisblanc BP, Gimenez CR, Espinoza LR. Slow development of massive splenomegaly, portal and pulmonary hypertension in systematic lupus erythematosus: can nodular regenerative hyperplasia of the liver explain all these findings? Lupus 2005; 14: 976-978
28. Daniel F, Cadranel JF, Seksik P, Cazier A, Duong Van Huyen JP, Ziol M, Coutarel P, Loison P, Jian R, Marteau P. Azathioprine induced nodular regenerative hyperplasia in IBD patients. Gastroenterol Clin Biol 2005; 29: 600-603
29. González-Alegre MT, Guerra-Vales JM, Martínez-González, Gutiérrez A, Guillen V. Nodular regenerative hyperplasia of the liver and Hodgkin's disease: a case report. Acta Gastroenterol Belg 2004; 67: 358-360
30. Jawaid Q, Saeed ZA, Di Bisceglie AM, Brunt EM, Ramrakhiani S, Varma CR, Solomon H. Biliary-venous fistula complicating transjugular intrahepatic portosystemic shunt presenting with recurrent bacteremia, jaundice, anemia and fever. Am J Transplant 2003; 3: 1604-1607
31. Gento Peña E, Martín Lorente JL, Echevarría Iturbe C, Pérez Alvarez JC, Sáez-Royuela F, López Morante A, Ojeda Giménez C. [Sinusoidal portal hypertension secondary to nodular regenerative hyperplasia of the liver]. Gastroenterol Hepatol 1999; 22: 183-185
32. Kaburaki J, Kuramochi S, Fujii T, Kuwana M, Tojo T, Ikeda Y, Hosada Y. Nodular regenerative hyperplasia of the liver in a patient with systemic sclerosis. Clin Rheumatol 1996; 15: 613-616
33. Henkel M, Paquet KJ, Rühl U. [Correlation between pulmonary hypertension and portal hypertension--2 case reports of different forms of pre-sinusoidal portal hypertension]. Leber Magen Darm 1994; 24: 10-14
34. Calès P, Voigt JJ, Payen JL, Bloom E, Berg P, Vinel JP, Pradère B, Broussy P, Pascal JP. Diffuse vascular ectasia of the antrum, duodenum, and jejunum in a patient with nodular regenerative hyperplasia. Lack of response to portosystemic shunt or gastrectomy. Gut 1993; 34: 558-561
35. Portmann B, Stewart S, Higenbottam TW, Clayton PT, Lloyd JK, Williams R. Nodular transformation of the liver associated with portal and pulmonary arterial hypertension. Gastroenterology 1993; 104: 616-621
36. Trauner M, Stepan KM, Resch M, Ebner F, Pristautz H, Klimpfinger M. Diagnostic problems in nodular regenerative hyperplasia (nodular transformation) of the liver. Review of the literature and report of two cases. Z Gastroenterol 1992; 30: 187-194
37. Duvoux C, Kracht M, Lang P, Vernant JP, Zafrani ES, Dhumeaux D. [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy]. Gastroenterol Clin Biol 1991; 15: 968-973
38. Bedossa P, Ngendayo L, Hervé P, Rain B, Poynard T, Simonneau G. [Nodular regenerative hyperplasia and pulmonary arterial hypertension]. Gastroenterol Clin Biol 1990; 14: 881-884
39. Yutani C, Imakita M, Ishibashi-Ueda H, Okubo S, Naito M, Kunieda T. Nodular regenerative hyperplasia of the liver associated with primary pulmonary hypertension. Hum Pathol 1988; 19: 726-731
40. Kuramochi S, Tashiro Y, Torikata C, Watanabe Y. Systemic lupus erythematosus associated with multiple nodular hyperplasia of the liver. Acta Pathol Jpn 1982; 32: 547-560
41. Qizilbash AH, Castelli M. Nodular regenerative hyperplasia of the liver: diagnosis by liver biopsy. Can Med Assoc J 1980; 122: 1151-1154
42. Lebrec D, Capron JP, Dhumeaux D, Benhamou JP. Pulmonary hypertension complicating portal hypertension. AmRev Respir Dis 1979; 120: 849-856
43. Shorey J, Weinberg MN, Frenkel EP, Fallis BD. Nodular regenerative hyperplasia of the liver in a case of myelofibrosis with extramedullary hematopoiesis and secondary portal venous hypertension. Am J Clin Pathol 1979; 72: 122-125
44. Wechsler J, Belaiche J, Vesin P, Cattan D, Pinaudeau Y. [Anatomo-clinical study of a case of regenerative nodular hyperplasia of the liver with Felty's syndrome and portal hypertension]. Ann Anat Pathol (Paris) 1979; 24: 325-336
45. Riesco Díaz M, Manzano Gómez F, Tirado Domínguez M, Suárez García E, Pujol de laLlave E. [Rheumatoid arthritis and hepatic nodular regenerative hyperplasia]. Rev Clin Esp 1994; 194: 70
46. Bills LJ, Seibert D, Brick JE. Liver disease, erroneously attributed to methotrexate, in a patient with rheumatoid arthritis. J Rheumatol 1992; 19: 1963-1965
47. Young ID, Segura J, Ford PM, Ford SE. The pathogenesis of nodular regenerative hyperplasia of the liver associated with rheumatoid vasculitis. J Clin Gastroenterol 1992; 14: 127-131
48. Perez Ruiz F, Orte Martinez FJ, Zea Mendoza AC, Ruiz del Arbol L, Moreno Caparros A. Nodular regenerative hyperplasia of the liver in rheumatic diseases: report of seven cases and review of the literature. Semin Arthritis Rheum 1991; 21: 47-54
49. Forbes GM, Shilkin KB, Reed WD. Nodular regenerative hyperplasia of the liver: the importance of combined macroscopic and microscopic findings. Med J Aust 1991; 154: 415-417
50. Nakad A, Moens P, Najm S, Haot J, Janssen J, Geubel AP. Nodular regenerative hyperplasia of the liver and esophageal varices in Felty's syndrome: a clinicopathologic case report with review of the literature. Acta Clin Belg 1988; 43: 45-50
51. Reynolds WJ, Wanless IR. Nodular regenerative hyperplasia of the liver in a patient with rheumatoid vasculitis: a mor-phometric study suggesting a role for hepatic arteritis in the pathogenesis. J Rheumatol 1984; 11: 838-842
52. Cohen MD, Ginsburg WW, Allen GL. Nodular regenerative hyperplasia of the liver and bleeding esophageal varices in Felty's syndrome: a case report and literature review. J Rheumatol 1982; 9: 716-718
53. Wanless IR, Godwin TA, Allen F, Feder A. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. Medicine (Baltimore) 1980; 59: 367-379
54. Belaiche J, Vesin P, Fischer D, Wechsler J, Franco D, Bismuth H, Cattan D. [Nodular regenerative hyperplasia of the liver with portal hypertension associated with Felty's syndrome. Report of a case (author's transl)]. Gastroenterol Clin Biol 1978; 2: 63-70
55. Reisman T, Levi JU, Zeppa R, Clark R, Morton R, Schiff ER. Noncirrhotic portal hypertension in Felty's syndrome. Am J Dig Dis 1977; 22: 145-148
56. Schouten JN, Verheij J, Janssen HL. [Non-cirrhotic portal hypertension: rare cause of upper gastrointestinal bleeding]. Ned Tijdschr Geneeskd 2010; 154: A1276
57. Bihl F, Janssens F, Boehlen F, Rubbia-Brandt L, Hadengue A, Spahr L. Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient. BMC Gastroenterol 2010; 10: 6
58. Mendizabal M, Craviotto S, Chen T, Silva MO, Reddy KR. Noncirrhotic portal hypertension: another cause of liver disease in HIV patients. Ann Hepatol 2009; 8: 390-395
59. Kochin I, Magid M, Arnon R, Glasscock A, Kerkar N, Miloh T. Variceal bleeding in an adolescent with HIV diagnosed with hepatoportal sclerosis and nodular regenerative hyperplasia. J Pediatr Gastroenterol Nutr 2010; 50: 340-343
60. Dinh MH, Stosor V, Rao SM, Miller FH, Green RM. Cryptogenic liver disease in HIV-seropositive men. HIV Med 2009; 10: 447-453
61. Ding A, Lee A, Callender M, Loughrey M, Quah SP, Dinsmore WW. Hepatic encephalopathy as an unusual late complication of transjugular intrahepatic portosystemic shunt insertion for non-cirrhotic portal hypertension caused by nodular regenerative hyperplasia in an HIV-positive patient on highly active antiretroviral therapy. Int J STD AIDS 2010; 21: 71-72
62. Tateo M, Sebagh M, Bralet MP, Teicher E, Azoulay D, Mallet V, Pol S, Castaing D, Samuel D, Duclos-Vallée JC. A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients. Liver Transpl 2008; 14: 1194-1198
63. Podevin P, Spiridon G, Terris B, Chauvelot-Moachon L, Guillevin L, Chaussade S, Sogni P, Salmon-Ceron D. Nodular regenerative hyperplasia of the liver after IL-2 therapy in anHIV-infected patient. AIDS 2006; 20: 313-315
64. Fernandez-Miranda C, Colina F, Delgado JM, Lopez-Carreira M. Diffuse nodular regenerative hyperplasia of the liver associated with human immunodeficiency virus and visceral leishmaniasis. Am J Gastroenterol 1993; 88: 433-435
65. Leung VK, Loke TK, Luk IS, Ng WL, Chau TN, Law ST, Chan JC. Nodular regenerative hyperplasia of the liver associated with systemic lupus erythematosus: three cases. Hong Kong Med J 2009; 15: 139-142
66. Leung VK, Ng WL, Luk IS, Chau TN, Chan WH, Kei SK, Loke TK. Unique hepatic imaging features in a patient with nodular regenerative hyperplasia of the liver associating with systemic lupus erythematosus. Lupus 2007; 16: 205-208
67. Horita T, Tsutsumi A, Takeda T, Yasuda S, Takeuchi R, Amasaki Y, Ichikawa K, Atsumi T, Koike T. Significance of magnetic resonance imaging in the diagnosis of nodular regenerative hyperplasia of the liver complicated with systemic lupus erythematosus: a case report and review of the literature. Lupus 2002; 11: 193-196
68. Sekiya M, Sekigawa I, Hishikawa T, Iida N, Hashimoto H, Hirose S. Nodular regenerative hyperplasia of the liver in systemic lupus erythematosus. The relationship with anticardiolipin antibody and lupus anticoagulant. Scand J Rheumatol 1997; 26: 215-217
69. Guitton P, Touchard G, Beauchant M. [Diffuse nodular regenerative hyperplasia of the liver and disseminated lupus erythematosus]. Gastroenterol Clin Biol 1987; 11: 102-103
70. Klemp P, Timme AH, Sayers GM. Systemic lupus erythematosus and nodular regenerative hyperplasia of the liver. Ann Rheum Dis 1986; 45: 167-170
71. Bryant DL, Miles CJ, Gearry RB. Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease. N Z Med J 2010; 123: 74-76
72. Schumann M, Preiss JC, Loddenkemper C, Günther U, Somasundaram R, Siegmund B, Zeitz M. [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease]. Dtsch Med Wochenschr 2008; 133: 1897-1900
73. Ansari A, Elliott T, Fong F, Arenas-Hernandez M, Rottenberg G, Portmann B, Lucas S, Marinaki A, Sanderson J. Further experience with the use of 6-thioguanine in patients with Crohn's disease. Inflamm Bowel Dis 2008; 14: 1399-1405
74. Ehmsen L, Marko C, Breidert M. [Portal vein hypertension during azathioprine therapy in patients with Crohn's disease--a frequent phenomenon?]. Dtsch Med Wochenschr 2008; 133: 950-953
75. Arnott ID, Ghosh S. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury. Eur J Gastroenterol Hepatol 2000; 12: 569-573
76. Tinsa F, Brini I, El May A, Bousnina D, Boussetta K, Bousnina S. Nodular regenerative hyperplasia of the liver, celiac disease and Sjogren's syndrome in a child. Gastroenterol Clin Biol 2010; 34: 40-42
77. Biecker E, Trebicka J, Fischer HP, Sauerbruch T, Lammert F. Portal hypertension and nodular regenerative hyperplasiain a patient with celiac disease. Z Gastroenterol 2006; 44: 395-398
78. Cancado EL, Medeiros DM, Deguti MM, Dos Santos MS, de Mello ES, Vendramini MB, Carrilho FJ. Celiac disease associated with nodular regenerative hyperplasia, pulmonary abnormalities, and IgA anticardiolipin antibodies. J Clin Gastroenterol 2006; 40: 135-139
79. Austin A, Campbell E, Lane P, Elias E. Nodular regenerative hyperplasia of the liver and coeliac disease: potentialrole of IgA anticardiolipin antibody. Gut 2004; 53: 1032-1034
80. Riestra S, Domínguez F, Rodrigo L. Nodular regenerative hyperplasia of the liver in a patient with celiac disease. J Clin Gastroenterol 2001; 33: 323-326
81. Agard C, Ponge T, Mahé B, Barrier J. [Lymphocytic lymphoma and regenerative liver nodular hyperplasia in systemic scleroderma]. Rev Med Interne 2000; 21: 301-303
82. McMahon RF, Babbs C, Warnes TW. Nodular regenerative hyperplasia of the liver, CREST syndrome and primary biliary cirrhosis: an overlap syndrome? Gut 1989; 30: 1430-1433
83. García Díaz JD, Praga Terente M, Colina Ruizdelgado F, Lizasoaín Hernández M, Mesa Latorre J. [Nodular regenerative hyperplasia of the liver associated with a CREST syndrome with multiorgan involvement]. An Med Interna 1989; 6: 203-206
84. Cadranel JF, Grippon P, Wechsler B, Bidegaray E, Karkouche B, Opolon P. [The CRST syndrome and nodular regenerative hyperplasia of the liver. A case]. Presse Med 1987; 16: 1656
85. Friguet JL, Deugnier Y, Messner M, Lauvin R, Launois B, Brissot P, Ferrand B, Bourel M. [Regenerative nodular hyperplasia in scleroderma: a new case]. Gastroenterol Clin Biol 1984; 8: 979
86. Gaya DR, Oien KA, Stanley AJ, Morris AJ. Bleeding gastric varices and antiphospholipid syndrome. Nat Clin Pract Gas-troenterol Hepatol 2005; 2: 156-159; quiz 1 p following 159
87. Morlà RM, Ramos-Casals M, García-Carrasco M, Cervera R, Font J, Bruguera M, Rojas-Rodríguez J, Ingelmo M. Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature. Lupus 1999; 8: 160-163
88. Cadranel JF, Demontis R, Guettier C, Bouraya D, Dautreaux M, Ghazali A, Poux JM, Coutarel P, Devergie B, Fievet P. [Nodular regenerative hyperplasia associated with primary antiphospholipid syndrome]. Gastroenterol Clin Biol 1996; 20: 901-904
89. Keegan AD, Brooks LT, Painter DM. Hepatic infarction and nodular regenerative hyperplasia of the liver with associated anticardiolipin antibodies in a young woman. J Clin Gastroenterol 1994; 18: 309-313
90. Devaney K, Goodman ZD, Epstein MS, Zimmerman HJ, Ishak KG. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 1993; 17: 1272-1280
91. Toso C, Isse K, Demetris AJ, Dinyari P, Koh A, Imes S, Kin T, Emamaullee J, Senior P, Shapiro AM. Histologic graft assessment after clinical islet transplantation. Transplantation 2009; 88: 1286-1293
92. Pezzullo L, Muretto P, De Rosa G, Picardi M, Lucania A, Rotoli B. Liver nodular regenerative hyperplasia after bone marrow transplant. Haematologica 2000; 85: 669-670
93. Ichikawa Y, Kyo M, Hanafusa T, Kohro T, Kishikawa H, Fukunishi T, Nagano S, Shinji Y. A 20-year case study of a kidney transplant recipient with chronic active hepatitis C: clinical course and successful treatment for late acute rejection induced by interferon therapy. Transplantation 1998; 65: 134-138
94. Sebagh M, Farges O, Samuel D, Bismuth H, Reynès M. Nodular regenerative hyperplasia of the liver following orthotopic liver transplantation. Transplant Proc 1995; 27: 2510-2511
95. Xerri L, Payan MJ, Choux R, Gros N, Hassoun J, Chamlian A, Blin D, Monties JR. An exceptional 18-year follow-up after cardiac transplantation. How can malignancies occur during immunosuppressive therapy? Cancer 1989; 63: 1697-1699
96. Jones MC, Best PV, Catto GR. Is nodular regenerative hyperplasia of the liver associated with azathioprine therapy after renal transplantation? Nephrol Dial Transplant 1988; 3: 331-333
97. Buffet C, Cantarovitch M, Pelletier G, Fabre M, Martin E, Charpentier B, Etienne JP, Fries D. Three cases of nodular regenerative hyperplasia of the liver following renal transplantation. Nephrol Dial Transplant 1988; 3: 327-330
98. Morales JM, Prieto C, Colina F, Mestre MJ, Lopez I, Perez-Sola A, Solis Herruzo JA, Ruilope LM, Rodicio JL. Nodular regenerative hyperplasia of the liver in renal transplantation. Transplant Proc 1987; 19: 3694-3696
99. Bredfeldt JE, Havey AL. Nodular regenerative hyperplasia of the liver following renal transplantation. Dig Dis Sci 1981; 26: 271-274
100. van den Broek MA, Olde Damink SW, Driessen A, Dejong CH, Bemelmans MH. Nodular regenerative hyperplasia secondary to neoadjuvant chemotherapy for colorectal liver metastases. Case Report Med 2009; 2009: 457975
101. Citak EC, Karadeniz C, Oguz A, Boyunaga O, Ekinci O, Okur V. Nodular regenerative hyperplasia and focal nodular hyperplasia of the liver mimicking hepatic metastasis in children with solid tumors and a review of literature. Pediatr Hematol Oncol 2007; 24: 281-289
102. Chu WC, Roebuck DJ. Nodular regenerative hyperplasia of the liver simulating metastases following treatment for bilateral Wilms tumor. Med Pediatr Oncol 2003; 41: 85-87
103. Minato H, Nakanuma Y. Nodular regenerative hyperplasia of the liver associated with metastases of pancreatic endocrine tumour: report of two autopsy cases. Virchows Arch A Pathol Anat Histopathol 1992; 421: 171-174
104. Cervera R, Abós J, Bruguera M, Grau JM. [Regenerative nodular hepatic hyperplasia and gastric carcinoma]. Rev Clin Esp 1987; 181: 341-342
105. Kataoka TR, Tsukamoto Y, Kanazawa N, Izumi T, Awata N, Nishizawa Y, Ohsawa M, Ishiguro S. Concomitant hepatocellular carcinoma and non-Hodgkin's lymphoma in a patient with nodular regenerative hyperplasia. Pathol Int 2006; 56: 279-282
106. Kiyuna A, Sunagawa T, Hokama A, Touyama M, Tomiyama R, Sakugawa H, Kinjo F, Saito A. Nodular regenerative hyperplasia of the liver and Castleman's disease: potential role of interleukin-6. Dig Dis Sci 2005; 50: 314-316
107. Iwabe C, Hashimoto E, Aoka K, Watanabe U, Hayashi N. [A case of non-Hodgkin's lymphoma with portal hypertension and nodular regenerative hyperplasia]. Nippon Shokakibyo Gakkai Zasshi 1994; 91: 2239-2243
108. Feng WJ, Takayasu K, Konda C, Yamazaki S, Sakamoto M, Hirohashi S, Takenaka T. CT of nodular hyperplasia of the liver in non-Hodgkin lymphoma. J Comput Assist Tomogr 1991; 15: 1031-1034
109. Mesa Latorre J, de Dios García Díaz J, Larregla Garraus S, Ortiz Conde MC. [Nodular regenerative hyperplasia of the liver and acute lymphoblastic leukemia]. Rev Clin Esp 1990; 186: 192-193
110. Zuber M, Gherardi R, Defer G, Gaulard P, Divine M, Zafrani ES. Peripheral neuropathy, coagulopathy and nodular regenerative hyperplasia of the liver in a patient with multiple serologic auto-antibody activities and IgM B-cell lymphoma. J Intern Med 1989; 226: 291-295
111. Ramos Soria F, Puig Pujol X, Vida Mombiela F, Badal Alter JM. [Hemoperitoneum as the first manifestation of hepatic regenerative nodular hyperplasia associated with Hodgkin's lymphoma]. Rev Clin Esp 1989; 184: 333
112. Rozman M, Montserrat E, Bruguera M, Grau JM, Terés J, Rozman C. [Chronic lymphatic leukemia and portal hypertension: a causal association?]. Med Clin (Barc) 1989; 92: 26-28
113. Kitazono M, Saito Y, Kinoshita M, Nakashima T, Kojiro M, Tanaka H. Nodular regenerative hyperplasia of the liver in a patient with multiple myeloma and systemic amyloidosis. Acta Pathol Jpn 1985; 35: 961-967
114. Voinchet O, Degott C, Scoazec JY, Feldmann G, Benhamou JP. Peliosis hepatis, nodular regenerative hyperplasia of theliver, and light-chain deposition in a patient with Waldenström's macroglobulinemia. Gastroenterology 1988; 95: 482-486
115. Wanless IR, Solt LC, Kortan P, Deck JH, Gardiner GW, Prokipchuk EJ. Nodular regenerative hyperplasia of the liver associated with macroglobulinemia. A clue to the pathogenesis. Am J Med 1981; 70: 1203-1209
116. García Buey L, García Sánchez A, Moreno Otero R, González Estecha A, Pozo A, Pajares JM. [Hepatic nodular regenerative hyperplasia associated with essential mixed cryoglobulinemia]. Rev Clin Esp 1987; 181: 285-287
117. Mignon F, Ronco P, Verroust P, Poupon R, Prudomme de SaintMaur P, Morel-Maroger L. [Nephropathy and nodular regenerative hyperplasia of the liver (author's transl)]. Nephrologie 1980; 1: 23-26
118. Carbone J, Escudero A, Mayayo M, Ballesteros M, Perez-Corral A, Sanchez-Ramon S, Sarmiento E, Micheloud D, Fernandez-Cruz E. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. Ann N Y Acad Sci 2005; 1051: 666-671
119. Hilario Rodríguez E, Velasco Oses A, Coma y del Corral MJ, Sáenz García JA. [Diffuse nodular regenerative hyperplasia of the liver associated with autoimmune hemolytic anemia. Presentation of a case and review of the literature]. Rev Esp Enferm Apar Dig 1983; 63: 45-51
120. Castellano G, Colina F, Moreno D, Pinedo F, Canga F, SolísHerruzo JA. [Nodular regenerative hepatic hyperplasia associated with primary biliary cirrhosis]. Rev Clin Esp 1992; 191: 433-434
121. Buffet C, Sinico M, Adda G, Fabre M, Roge J, Pelletier G, Martin E, Etienne JP. [Nodular regenerative hyperplasia and primary biliary cirrhosis]. Gastroenterol Clin Biol 1991; 15: 856-858
122. Chazouillères O, Andreani T, Legendre C, Poupon R, Darnis F. [Nodular regenerative hyperplasia of the liver and primary biliary cirrhosis. A fortuitous association?]. Gastroenterol Clin Biol 1986; 10: 764-766
123. Mones JM, Saldana MJ, Albores-Saavedra J. Nodular regenerative hyperplasia of the liver. Report of three cases and review of the literature. Arch Pathol Lab Med 1984; 108: 741-743
124. Mones JM, Saldana MJ. Nodular regenerative hyperplasia of the liver in a 4-month-old infant. Am J Dis Child 1984; 138: 79-81
125. Grazioli L, Alberti D, Olivetti L, Rigamonti W, Codazzi F, Matricardi L, Fugazzola C, Chiesa A. Congenital absence of portal vein with nodular regenerative hyperplasia of the liver. Eur Radiol 2000; 10: 820-825
126. Arana E, Martí-Bonmatí L, Martínez V, Hoyos M, Montes H. Portal vein absence and nodular regenerative hyperplasia of the liver with giant inferior mesenteric vein. Abdom Imaging 1997; 22: 506-508
127. Buchel O, Roskams T, Van Damme B, Nevens F, Pirenne J, Fevery J. Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia. Gut 2005; 54: 1021-1023
128. Talbot-Smith A, Syn WK, MacQuillan G, Neil D, Elias E, Ryan P. Familial idiopathic pulmonary fibrosis in association with bone marrow hypoplasia and hepatic nodular regenerative hyperplasia: a new trimorphic syndrome. Thorax 2009; 64: 440-443
129. Haboubi NY, Smith VJ, Coyne JD, Ackrill P. Nodular regenerative hyperplasia of the liver in a non-treated patient with mesangiocapillary glomerulonephritis. Histopathology 1991; 18: 367-368
130. Haratake J, Horie A, Takasugi M, Hiroshige K. Nodular regenerative hyperplasia of the liver associated with idiopathic membranous glomerulonephritis. Am J Gastroenterol 1987; 82: 677-680
131. McCulloch AJ, Morley AR, Wilkinson R, Lesna M. Nodular regenerative hyperplasia of the liver with membranous glomerulonephritis. Postgrad Med J 1981; 57: 402-403
132. Fonseca V, Havard CW. Portal hypertension secondary to azathioprine in myasthenia gravis. Postgrad Med J 1988; 64: 950-952
133. Eliakim R, Ligumsky M, Jurim O, Shouval D. Nodular regenerative hyperplasia with portal hypertension in a patient with myasthenia gravis. Am J Gastroenterol 1987; 82: 674-676
134. Goritsas CP, Repanti M, Papadaki E, Lazarou N, Andonopoulos AP. Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa. J Hepatol 1997; 26: 727-730
135. Nakanuma Y, Ohta G, Sasaki K. Nodular regenerative hyperplasia of the liver associated with polyarteritis nodosa. Arch Pathol Lab Med 1984; 108: 133-135
136. Sasaki M, Hodo Y, Nakanuma Y. Hepatocellular carcinoma arising in primary biliary cirrhosis presenting with nodular regenerative hyperplasia: report of an autopsy case. J Gastroenterol Hepatol 2006; 21: 1866-1868
137. Ravindran J, Gillis D, Rowland R, Heddle R. Common variable immunodeficiency associated with nodular regenerative hyperplasia of the liver. Aust N Z J Med 1995; 25: 741
138. Thevenot T, Dhote R, Tulliez M, Baverel F, Permal S, Rabineau D, Christoforov B. [Turner syndrome and nodular regenerative hyperplasia of the liver]. Ann Med Interne (Paris) 1998; 149: 295-296
139. de Lédinghen V, Levillain P, Besson I, Palazzo L, Fabre M, Silvain C, Morichau-Beauchant M. [Nodular regenerative hyperplasia of the liver and Turner syndrome]. Gastroenterol Clin Biol 1994; 18: 898-899
140. Molina T, Delmer A, Le Tourneau A, Texier P, Degott C, Audoin J, Zittoun R, Diebold J. Hepatic lesions of vascular origin in multicentric Castleman's disease, plasma cell type: report of one case with peliosis hepatis and another with perisinusoidal fibrosis and nodular regenerative hyperplasia. Pathol Res Pract 1995; 191: 1159-1164
141. Nakamura Y, Takeuchi T, Kanaoka H, Okanoue T, Kashima K. [A case of nodular regenerative hyperplasia of liver withidiopathic hypereosinophilic syndrome]. Nippon Shokakibyo Gakkai Zasshi 1997; 94: 44-48
142. Baker BL, Axiotis C, Hurwitz ES, Leavitt R, Di Bisceglie AM. Nodular regenerative hyperplasia of the liver in idiopathichypereosinophilic syndrome. J Clin Gastroenterol 1991; 13: 452-456
143. Morris JM, Oien KA, McMahon M, Forrest EH, Morris J, Stanley AJ, Campbell S. Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series. Eur J Gastroenterol Hepatol 2010; 22: 1001-1005
144. Wang HM, Lo GH, Hsu PI, Lin CK, Chan HH, Chen WC, Lai KH, Wang BW, Lin SL. Nodular regenerative hyperplasia of the liver. J Chin Med Assoc 2008; 71: 523-527
145. Ziol M, Poirel H, Kountchou GN, Boyer O, Mohand D, Mouthon L, Tepper M, Guillet JG, Guettier C, Raphael M, Beaugrand M. Intrasinusoidal cytotoxic CD8+ T cells in nodular regenerative hyperplasia of the liver. Hum Pathol 2004; 35: 1241-1251
146. Al-Mukhaizeem KA, Rosenberg A, Sherker AH. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am J Hematol 2004; 75: 225-230
147. Ferlitsch A, Teml A, Reinisch W, Ulbrich G, Wrba F, Homoncik M, Gangl A, Peck-Radosavljevic M, Vogelsang H. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension. Am J Gastroenterol 2007; 102: 2495-2503
148. Ueno S, Tanabe G, Sueyoshi K, Yoshinaka H, Yamamoto S, Kurita K, Yoshidome S, Nuruki K, Aikou T. Hepatic hemodynamics in a patient with nodular regenerative hyperplasia. Am J Gastroenterol 1996; 91: 1012-1015
149. Clouet M, Boulay I, Boudiaf M, Soyer P, Nemeth J, Kiselman R, Rymer R. Imaging features of nodular regenerative hyperplasia of the liver mimicking hepatic metastases. Abdom Imaging 1999; 24: 258-261
150. Casillas C, Martí-Bonmatí L, Galant J. Pseudotumoral presentation of nodular regenerative hyperplasia of the liver: imaging in five patients including MR imaging. Eur Radiol 1997; 7: 654-658
151. Rha SE, Lee MG, Lee YS, Kang GH, Ha HK, Kim PN, Auh YH. Nodular regenerative hyperplasia of the liver in Budd- Chiari syndrome: CT and MR features. Abdom Imaging 2000; 25: 255-258
152. Zech CJ, Seiderer J, Reinisch W, Ochsenkuhn T, Schima W, Diebold J, Wrba F, Reiser MF, Schoenberg SO. Thioguanininduced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques. Eur Radiol 2007; 17: 1898-1905
153. Laharie D, Vergniol J, Bioulac-Sage P, Diris B, Poli J, Foucher J, Couzigou P, Drouillard J, de Lédinghen V. Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver. Eur J Gastroenterol Hepatol 2010; 22: 487-493
154. Ames JT, Federle MP, Chopra K. Distinguishing clinical and imaging features of nodular regenerative hyperplasia and large regenerative nodules of the liver. Clin Radiol 2009; 64: 1190-1195
155. Dachman AH, Ros PR, Goodman ZD, Olmsted WW, Ishak KG. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. AJR Am J Roentgenol 1987; 148: 717-722
156. Ibarrola C, Colina F. Clinicopathological features of nine cases of non-cirrhotic portal hypertension: current definitions and criteria are inadequate. Histopathology 2003; 42: 251-264
157. Arvanitaki M, Adler M. Nodular regenerative hyperplasia of the liver. A review of 14 cases. Hepatogastroenterology 2001; 48: 1425-1429
158. Seiderer J, Zech CJ, Diebold J, Schoenberg SO, Brand S, Tillack C, Göke B, Ochsenkühn T. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy. Eur J Gastroenterol Hepatol 2006; 18: 553-555
159. Krishna M, Keaveny AP, Genco PV, Rosser BG, Dickson RC, Nguyen JH, Steers JL, Nakhleh RE. Clinicopathological review of 18 cases of liver allografts lost due to bile duct necrosis. Transplant Proc 2005; 37: 2221-2223
160. Radomski JS, Chojnacki KA, Moritz MJ, Rubin R, Armenti VT, Wilson GA, Herrine S, Conn M. Results of liver transplantation for nodular regenerative hyperplasia. Am Surg 2000; 66: 1067-1070
161. Loinaz C, Colina F, Musella M, Lopez-Rios F, Gomez R, Jimenez C, Gonzalez Pinto I, Garcia I, Moreno Gonzalez E. Orthotopic liver transplantation in 4 patients with portal hypertension and non-cirrhotic nodular liver. Hepatogastroenterology 1998; 45: 1787-1794
162. Dumortier J, Bizollon T, Scoazec JY, Chevallier M, Bancel B, Berger F, Ducerf C, Claudel-Bonvoisin S, Paliard P, Boillot O, Trepo C. Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome. Scand J Gastroenterol 2001; 36: 417-422
163. Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. Am J Gastroenterol 1996; 91: 879-884
164. Kobayashi S, Saito K, Nakanuma Y. Nodular regenerative hyperplasia of the liver in hepatocellular carcinoma. An autopsy study. J Clin Gastroenterol 1993; 16: 155-159
165. Stromeyer FW, Ishak KG. Nodular transformation (nodular regenerative hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 1981; 12: 60-71
166. Russmann S, Zimmermann A, Krähenbühl S, Kern B, Reichen J. Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol 2001; 13: 287-290
167. Thung SN, Gerber MA. Enzyme pattern and marker antigens in nodular regenerative hyperplasia of the liver. Cancer 1981; 47: 1796-1799
168. Di Gioia S, Bianchi P, Destro A, Grizzi F, Malesci A, Laghi L, Levrero M, Morabito A, Roncalli M. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver. BMC Cancer 2006; 6: 89
169. Pewzner-Jung Y, Brenner O, Braun S, Laviad EL, Ben-Dor S, Feldmesser E, Horn-Saban S, Amann-Zalcenstein D, Raanan C, Berkutzki T, Erez-Roman R, Ben-David O, Levy M, Holzman D, Park H, Nyska A, Merrill AH Jr, Futerman AH. A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy. J Biol Chem 2010; 285: 10911-10923